Literature DB >> 1124105

Total eosinophil counts in the management of bronchial asthma.

B R Horn, E D Robin, J Theodore, A Van Kessel.   

Abstract

Total eosinophil counts were investigated in asthmatic patients to determine their usefulness in the diagnosis and management of steroid-dependent asthma. Counts averaged 122 plus or minus 74 (S.D.) per mm-3 (65 untreated normal subjects) and 43 plus or minus 22 per mm-3 (six prednisone-treated normal subjects). Fifty-two patients with active bronchial asthma showed significant eosinophilia (greater than 350/mm-3 off and greater than 85/mm-3 on steroids), suggesting that eosinophilia is an important diagnostic feature of bronchial asthma. In 14 patients (60 observations), the counts showed significant inverse correlation with specific airway conductance--r equals 0.74, p less than 0.001--and with a variety of other measurements of bronchial dynamics and lung volumes, suggesting that the total eosinophil count reflects asthmatic activity and is useful for regulating steroid dosage and for early detection of exacerbations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124105     DOI: 10.1056/NEJM197505292922204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  53 in total

Review 1.  Childhood asthma--advances in pathogenesis.

Authors:  N Somu; N C Gowrishankar; L Subramaniam; D Vijayasekaran; B M Muhajir; A Balachandran
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

Review 2.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

4.  The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.

Authors:  L H Faccioli; S Nourshargh; R Moqbel; F M Williams; R Sehmi; A B Kay; T J Williams
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

Review 5.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

Review 6.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

7.  Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

Authors:  P F Weller; C W Lee; D W Foster; E J Corey; K F Austen; R A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.

Authors:  C J Whelan; M Johnson
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

9.  Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF.

Authors:  M P Hallsworth; M A Giembycz; P J Barnes; T H Lee
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

10.  Evaluation of Antiasthmatic Activity of Curculigo orchioides Gaertn. Rhizomes.

Authors:  Pranali Pandit; Anita Singh; A R Bafna; P V Kadam; M J Patil
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.